| Trial ID: | L4849 |
| Source ID: | NCT00797823
|
| Associated Drug: |
Insulin, Asp(B28)-
|
| Title: |
Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00797823/results
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Insulin, Asp(B28)-|DRUG: Glucagon|DRUG: Placebo
|
| Outcome Measures: |
Primary: Effectiveness of Closed Loop Diabetes Control, Effectiveness of closed loop diabetes control will be measured by mean glucose., 1 year | Secondary: Percent of Time Venous Blood Glucose <70 mg/dl, 1 year
|
| Sponsor/Collaborators: |
Sponsor: Legacy Health System | Collaborators: Juvenile Diabetes Research Foundation|Oregon Health and Science University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-11
|
| Completion Date: |
2009-09
|
| Results First Posted: |
2011-09-26
|
| Last Update Posted: |
2011-10-07
|
| Locations: |
Legacy Research, Portland, Oregon, 97232, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00797823
|
